EVOMMUNE INC (EVMN:NYSE)
$13.21 -0.3 (-2.2206%)
Analysed EVOMMUNE INC (EVMN:NYSE) News Sources
Biotech’s IPO comeback; Trump’s tariff loophole for pharma
10-04-2026
pharmavoice.com
Evommune's Chronic-Hives Drug May See Wider Use If Trial Succeeds, RBC Says
10-04-2026
yahoo.com
Companies Like Evommune (NYSE:EVMN) Are In A Position To Invest In Growth
11-05-2026
yahoo.com
Velan Capital Drops 140,000 Mineralys Therapeutics (MLYS) Shares Worth $4.1 Million
31-05-2026
fool.com
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles
08-06-2026
fool.com
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
24-06-2026
yahoo.com
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria
29-06-2026
yahoo.com
Evommune Shares Slide After Phase 2b CSU Trial Misses Main Goal (EVMN)
29-06-2026
advfn.com
Evommune terminates oral drug’s development in CSU
29-06-2026
clinicaltrialsarena.com
EVMN Stock Tanks as Phase IIb Urticaria Study Misses Primary Goal
30-06-2026
yahoo.com
What is the current price of EVOMMUNE INC (EVMN:NYSE)?
The current price of EVOMMUNE INC (EVMN:NYSE) is $13.21.
EVOMMUNE INC (EVMN:NYSE) absolute price change since previous trading day?
The absolute price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is $-0.3.
EVOMMUNE INC (EVMN:NYSE) percentage price change since previous trading day?
The percentage price change of EVOMMUNE INC (EVMN:NYSE) since the previous trading day is -2.2206%.
What is the most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE)?
The most recent average sentiment score for EVOMMUNE INC (EVMN:NYSE) is 40 out of 100.
What is the most recent average sentiment for EVOMMUNE INC (EVMN:NYSE)?
The most recent sentiment for EVOMMUNE INC (EVMN:NYSE) is .
SEC-8K** Filing Available For EVOMMUNE INC (EVMN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.